Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06533904 · ClinicalTrials.gov registry record · NA
Percutaneous Cryoablation of Intercostal Nerves for the Treatment of Rib Fractures
A NA study, sponsored by Loma Linda University.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06533904: Clinical Trial NA study, sponsored by Loma Linda University.
NCT06533904 is a NA study that has not yet begun recruiting, run by Loma Linda University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06533904, a NA study, has not yet begun recruiting, sponsored by Loma Linda University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this double blinded randomized control trial is to learn if percutaneous cryoablation of traumatic rib fractures improves outcomes. The main questions it aims to answer are: Does percutaneous cryoablation improve short and long term pain scores? Does percutaneous cryoablation improve short and long term respiratory mechanics? Does percutaneous cryoablation improve long term quality of life? Does percutaneous cryoablation decrease delirium? Researchers will compare cryoablation to standard multimodal pain therapy to see if this impacts respiratory recovery. Participants will undergo randomization, percutaneous cryoablative procedure, and participate in tests at pre-determined intervals to evaluate their pulmonary recovery.
Primary Outcome
Short and Long Term Pain Scores. Range from 0 to 10 where 0 is no pain and 10 is most severe and worse outcome.
Interventions
- PROCEDURE Percutaneous Cryoablation of Intercostal Nerves
- OTHER Multi-modal pain regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-09 |
| Est. Completion | 2028-07 |
| Phase | NA |
What is known before NCT06533904 opens enrollment
NCT06533904 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Percutaneous Cryoablation of Intercostal Nerves is the first listed.
NCT06533904 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06533904 about?
NCT06533904 is a clinical study titled "Percutaneous Cryoablation of Intercostal Nerves for the Treatment of Rib Fractures". The goal of this double blinded randomized control trial is to learn if percutaneous cryoablation of traumatic rib fractures improves outcomes. The main questions it aims to answer are: Does percutaneous cryoablation improve short and long term pain scores? Does percutaneous cryoablation improve sh...
What is the current status of trial NCT06533904?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-09. Estimated completion is 2028-07.
What interventions are being tested in trial NCT06533904?
The interventions under investigation include: Percutaneous Cryoablation of Intercostal Nerves (PROCEDURE), Multi-modal pain regimen (OTHER).
Who is sponsoring clinical trial NCT06533904?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06533904's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia